Evidence map›Paper›PMID 33361096›Full record

ArticleThe European respiratory journal2021

An integrated multiomic and quantitative label-free microscopy-based approach to study pro-fibrotic signalling in

Muzamil Majid Khan, Daniel Poeckel, Aliaksandr Halavatyi, Joanna Zukowska-Kasprzyk, Frank Stein, Johanna Vappiani, Daniel C Sevin, Christian Tischer, Nico Zinn, Jessica D Eley and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanobiology and Resolution of Lung Fibrosis.Annual review of physiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Optimizing miRNA transfection for screening in precision cut lung slices.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Innovative three-dimensional models for understanding mechanisms underlying lung diseases: powerful tools for translational research.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Engineering Dynamic 3D Models of Lung.Advances in experimental medicine and biology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Muzamil Majid KhanEuropean Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0002-8188-0251
Daniel PoeckelDiscovery Biology, Cellzome GmbH, GSK, Heidelberg, Germany.
Aliaksandr HalavatyiEuropean Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0002-9002-457X
Joanna Zukowska-KasprzykEuropean Molecular Biology Laboratory, Heidelberg, Germany.
Frank SteinEuropean Molecular Biology Laboratory, Heidelberg, Germany.
Johanna VappianiDiscovery Biology, Cellzome GmbH, GSK, Heidelberg, Germany.
Daniel C SevinDiscovery Biology, Cellzome GmbH, GSK, Heidelberg, Germany.
Christian TischerEuropean Molecular Biology Laboratory, Heidelberg, Germany.
Nico ZinnDiscovery Biology, Cellzome GmbH, GSK, Heidelberg, Germany.
Jessica D EleyNovel Human Genetics Research Unit, GSK, Stevenage, UK.
Natasja Stæhr GudmannNordic Bioscience, Herlev, Denmark.
Thomas MuleyLung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
Hauke WinterLung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
Andrew J FisherNewcastle University Translational and Clinical Research Institute and Institute of Transplantation, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK.
Carmel B NanthakumarNovel Human Genetics Research Unit, GSK, Stevenage, UK.
Giovanna BergaminiDiscovery Biology, Cellzome GmbH, GSK, Heidelberg, Germany.ORCID 0000-0002-9662-9502
Rainer PepperkokEuropean Molecular Biology Laboratory, Heidelberg, Germany pepperko@embl.de.
European Molecular Biology Laboratory · DEGerman Center for Lung Research · DEAge UK · GBHeidelberg University · DENewcastle upon Tyne Hospital · GBNordic Bioscience (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrosis can affect any organ, resulting in the loss of tissue architecture and function with often life-threatening consequences. Pathologically, fibrosis is characterised by the expansion of connective tissue due to excessive deposition of extracellular matrix (ECM) proteins, including the fibrillar forms of collagen. A significant limitation for discovering cures for fibrosis is the availability of suitable human models and techniques to quantify mature fibrillar collagen deposition as close as possible to human physiological conditions.Here we have extensively characterised an

Indexed as

MicroscopyPulmonary FibrosisFibrosisHumansLungProteomicsTransforming Growth Factor beta1Transforming Growth Factor beta1

Identifiers

PMID33361096
PMCPMC8318569
OpenAlexW3117172135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.